These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6343575)

  • 21. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mefloquine and sulfadoxine/pyrimethamine resistant Plasmodium falciparum.
    Arnold K
    Lancet; 1986 Jan; 1(8473):154. PubMed ID: 2867368
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of rabbit serum in the cultivation of Plasmodium falciparum.
    Sax LJ; Rieckmann KH
    J Parasitol; 1980 Aug; 66(4):621-4. PubMed ID: 6999144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular epidemiology of malaria in Cameroon. XXIII. Experimental studies on serum substitutes and alternative culture media for in vitro drug sensitivity assays using clinical isolates of Plasmodium falciparum.
    Basco LK
    Am J Trop Med Hyg; 2006 Nov; 75(5):777-82. PubMed ID: 17123965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrimethamine/sulfadoxine resistant falciparum malaria in East Africa.
    Timmermanns PM; Hess U; Jones ME
    Lancet; 1982 May; 1(8282):1181. PubMed ID: 6122952
    [No Abstract]   [Full Text] [Related]  

  • 26. Isolation and cultivation of Plasmodium falciparum using adult bovine serum.
    Divo AA; Vande Waa JA; Campbell JR; Jensen JB
    J Parasitol; 1985 Aug; 71(4):504-9. PubMed ID: 3897502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro cultivation of Plasmodium falciparum: studies with modified medium supplemented with ALBUMAX II and various animal sera.
    Srivastava K; Singh S; Singh P; Puri SK
    Exp Parasitol; 2007 Jun; 116(2):171-4. PubMed ID: 17275813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
    Djaman AJ; Basco LK; Mazabraud A
    Sante; 2002; 12(4):363-7. PubMed ID: 12626289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tissue culture media on multiplication of Plasmodium falciparum in vitro.
    Sutar NK; Sengupta SR; Renapurkar DM
    Indian J Malariol; 1992 Jun; 29(2):73-82. PubMed ID: 1459308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on serum requirements for the cultivation of Plasmodium falciparum. 2. Medium enrichment.
    Divo AA; Jensen JB
    Bull World Health Organ; 1982; 60(4):571-5. PubMed ID: 6754122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
    Del Nero L; Lamizana L; Pietra V; Nebié I
    Parassitologia; 1994 Dec; 36(3):287-93. PubMed ID: 7637999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Variability of in vitro activity of proguanil and cycloguanil on erythrocyte stages of Plasmodium falciparum as a function of culture conditions].
    Ndounga M; Basco LK; Ringwald P
    Bull Soc Pathol Exot; 1999 Dec; 92(5):313-6. PubMed ID: 10690466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The therapeutic efficacy of sulfadoxine/pyrimethamine against Plasmodium falciparum in Yemen.
    Al-Kabsi AM; Al-Shamahy HA; Al-Harazy AH; Harmal NS
    Med Princ Pract; 2009; 18(1):62-6. PubMed ID: 19060494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nutritional requirements of Plasmodium falciparum in culture. III. Further observations on essential nutrients and antimetabolites.
    Geary TG; Divo AA; Bonanni LC; Jensen JB
    J Protozool; 1985 Nov; 32(4):608-13. PubMed ID: 2866244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.
    Kamugisha J; Kipp W; Burnham G
    Trop Geogr Med; 1994; 46(6):364-5. PubMed ID: 7892705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parasitological rebound effect and emergence of pyrimethamine resistance in Plasmodium falciparum after single-dose sulfadoxine-pyrimethamine.
    Marks F; von Kalckreuth V; Kobbe R; Adjei S; Adjei O; Horstmann RD; Meyer CG; May J
    J Infect Dis; 2005 Dec; 192(11):1962-5. PubMed ID: 16267768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of Plasmodium falciparum to pyrimethamine in vivo and to sulphadoxine/pyrimethamine combination in vitro in pregnant women of northern Nigeria.
    Okoyeh JN; Lege-Oguntoye L; Emembolu JO; Sarki U; Slotboom AB
    J Trop Med Hyg; 1993 Feb; 96(1):56-9. PubMed ID: 8429576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fansidar-resistant falciparum malaria in Papua New Guinea.
    Nurse GT
    Lancet; 1981 Jan; 1(8210):36-7. PubMed ID: 6109064
    [No Abstract]   [Full Text] [Related]  

  • 39. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
    Osman ME; Mockenhaupt FP; Bienzle U; Elbashir MI; Giha HA
    Infect Genet Evol; 2007 Jan; 7(1):52-9. PubMed ID: 16690361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
    Méndez F; Herrera S; Murrain B; Gutiérrez A; Moreno LA; Manzano M; Muñoz A; Plowe CV
    Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.